Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 6.07JFL Life Sciences operates within the Healthcare Services industry, specifically hospitals and diagnostics. The company demonstrates notable strengths in solvency, growth, and coverage ratios. However, it shows weaknesses in liquidity, efficiency, financial metrics, and profitability. While the company exhibits strong growth and can comfortably cover its interest expenses, it struggles with generating profits and managing its short-term obligations. The absence of revenue growth and low financial ratios are areas that need attention. Overall, JFL Life Sciences needs to address its operational inefficiencies and enhance its profitability to ensure long-term sustainability. The company's strong growth and solvency provide a foundation for future improvement, but immediate action is required to tackle its current weaknesses.
Health Score : 6.07JFL Life Sciences operates within the Healthcare Services industry, specifically hospitals and diagnostics. The company demonstrates notable strengths in solvency, growth, and coverage ratios. However, it shows weaknesses in liquidity, efficiency, financial metrics, and profitability. While the company exhibits strong growth and can comfortably cover its interest expenses, it struggles with generating profits and managing its short-term obligations. The absence of revenue growth and low financial ratios are areas that need attention. Overall, JFL Life Sciences needs to address its operational inefficiencies and enhance its profitability to ensure long-term sustainability. The company's strong growth and solvency provide a foundation for future improvement, but immediate action is required to tackle its current weaknesses.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
6.75
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
13.51
P/B RATIO
1.88
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
0.69
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
8.06
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹13.1 as on Aug 6, 2026.
Growth Score : 8.00JFL Life Sciences demonstrates strong growth in several key areas, notably in operating profit, EPS, assets, and net income. These positive trends suggest a company that is expanding effectively. However, the absence of revenue growth is a concern. Addressing the lack of revenue growth while maintaining progress in other areas could lead to even stronger overall performance.
Revenue Growth RatePoorOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 3.03 | 26.47 | 9.3 | 74.47 | 59.76 |
| Operating Profit Growth Rate | 150 | -20 | 25 | 60 | 50 |
| Earnings Per Share (EPS) Growth | -60.67 | -27.12 | 16.28 | 26 | 53.97 |
| Asset Growth Rate | 65.52 | 2.08 | 16.33 | 26.32 | 47.22 |
| Net Income Growth Rate | 200 | 0 | 0 | 33.33 | 50 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medicamen Organics Ltd | 6.30 | -8.18 | Neutral | -3.75 | -2.50 | -4.02 |
| 2 | Mono Pharmacare Ltd | 6.16 | 4.71 | Neutral | 8.00 | 1.75 | 3.00 |
| 3 | JFL Life Sciences Ltd | 6.07 | 13.51 | Neutral | 12.00 | 1.94 | 6.00 |
| 4 | Walpar Nutritions Ltd | 5.29 | 13.25 | Neutral | 6.66 | 2.09 | 3.00 |
| 5 | Mangalam Drugs and Organics Ltd | 4.50 | -0.97 | Neutral | -15.00 | -27.68 | -44.00 |
| 6 | Lasa Supergenerics Ltd | 4.39 | -2.61 | Highly Undervalued | -7.00 | -6.80 | -34.00 |
| 7 | Sunrest Lifescience Ltd | 4.17 | 8.13 | Highly Undervalued | 10.21 | 3.60 | 8.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Cash Earnings Per Share (Cash EPS)